Short answer
Bicara Therapeutics Inc. (BCAX) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Quarterly results cover the period ended March 31, 2026.
Bicara Therapeutics Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Quarterly results cover the period ended March 31, 2026
- Press release issued May 11, 2026, with financial results and business updates
- Detailed figures and operating commentary are in Exhibit 99.1
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Bicara Therapeutics Inc. 8-K filings
Get the next BCAX 8-K as it lands
Follow BCAX for push alerts, or ask the research agent what this filing means.